Susquehanna International Group’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-79,000
| Closed | -$140K | – | 12551 |
|
|
2024
Q2 | $140K | Sell |
79,000
-225,900
| -74% | -$552K | ﹤0.01% | 10768 |
|
|
2024
Q1 | $826K | Buy |
+304,900
| New | +$736K | ﹤0.01% | 7341 |
|
|
2022
Q4 | – | Sell |
-14,900
| Closed | -$16K | – | 13100 |
|
|
2022
Q3 | $16K | Sell |
14,900
-9,900
| -40% | -$15K | ﹤0.01% | 12670 |
|
|
2022
Q2 | $40K | Sell |
24,800
-4,100
| -14% | -$10.1K | ﹤0.01% | 12090 |
|
|
2022
Q1 | $104K | Sell |
28,900
-48,000
| -62% | -$166K | ﹤0.01% | 11876 |
|
|
2021
Q4 | $301K | Sell |
76,900
-29,400
| -28% | -$138K | ﹤0.01% | 10487 |
|
|
2021
Q3 | $701K | Sell |
106,300
-28,400
| -21% | -$187K | ﹤0.01% | 8503 |
|
|
2021
Q2 | $830K | Sell |
134,700
-60,200
| -31% | -$322K | ﹤0.01% | 8276 |
|
|
2021
Q1 | $881K | Buy |
194,900
+1,100
| +0.6% | +$6.04K | ﹤0.01% | 8063 |
|
|
2020
Q4 | $1.16M | Sell |
193,800
-101,500
| -34% | -$667K | ﹤0.01% | 6364 |
|
|
2020
Q3 | $2.19M | Buy |
295,300
+257,400
| +679% | +$1.78M | ﹤0.01% | 4441 |
|
|
2020
Q2 | $152K | Buy |
+37,900
| New | +$132K | ﹤0.01% | 9250 |
|
|
2019
Q2 | – | Sell |
-20,700
| Closed | -$275K | – | 10565 |
|
|
2019
Q1 | $275K | Buy |
20,700
+5,000
| +32% | +$52.7K | ﹤0.01% | 7369 |
|
|
2018
Q4 | $135K | Sell |
15,700
-11,700
| -43% | -$91.1K | ﹤0.01% | 8058 |
|
|
2018
Q3 | $205K | Buy |
+27,400
| New | +$195K | ﹤0.01% | 8174 |
|
|
2018
Q2 | – | Sell |
-17,100
| Closed | -$100K | – | 10017 |
|
|
2018
Q1 | $100K | Sell |
17,100
-9,700
| -36% | -$63.7K | ﹤0.01% | 8702 |
|
|
2017
Q4 | $158K | Buy |
+26,800
| New | +$147K | ﹤0.01% | 8455 |
|
|
2016
Q4 | – | Sell |
-15,600
| Closed | -$125K | – | 9878 |
|
|
2016
Q3 | $125K | Sell |
15,600
-14,900
| -49% | -$137K | ﹤0.01% | 7855 |
|
|
2016
Q2 | $275K | Buy |
30,500
+9,100
| +43% | +$85.5K | ﹤0.01% | 7102 |
|
|
2016
Q1 | $173K | Sell |
21,400
-10,500
| -33% | -$75.7K | ﹤0.01% | 8091 |
|
|
2015
Q4 | $345K | Buy |
31,900
+4,800
| +18% | +$47.1K | ﹤0.01% | 7439 |
|
|
2015
Q3 | $220K | Buy |
27,100
+1,200
| +5% | +$18.9K | ﹤0.01% | 8567 |
|
|
2015
Q2 | $627K | Buy |
25,900
+9,700
| +60% | +$306K | ﹤0.01% | 7179 |
|
|
2015
Q1 | $682K | Buy |
+16,200
| New | +$640K | ﹤0.01% | 6539 |
|
|
2014
Q4 | – | Sell |
-19,800
| Closed | -$485K | – | 9871 |
|
|
2014
Q3 | $485K | Sell |
19,800
-1,700
| -8% | -$47.8K | ﹤0.01% | 7272 |
|
|
2014
Q2 | $632K | Buy |
21,500
+6,100
| +40% | +$195K | ﹤0.01% | 7022 |
|
|
2014
Q1 | $679K | Buy |
+15,400
| New | +$678K | ﹤0.01% | 6207 |
|
Other funds holding LAB
CC
MCO
LFCM
VCM
HBWM
Susquehanna International Group's LAB Position: Q1 2026 in Review
Susquehanna International Group increased its Standard BioTools (LAB) stake by 71% in Q1 2026, buying an estimated $76.8K and bringing the position to 153,343 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #12077.
Susquehanna International Group first reported a position in LAB in Q4 2013 and has held it in 38 quarters since. The position peaked at $5.68M in Q1 2024. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.
- Susquehanna International Group held 153,343 shares of Standard BioTools worth $141K as of Q1 2026.
- Susquehanna International Group bought 63,409 Standard BioTools shares in Q1 2026, an estimated $76.8K.
- Standard BioTools made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12077 holding.
- Susquehanna International Group first reported a position in Standard BioTools in Q4 2013 and has held it in 38 quarters since.
- Susquehanna International Group's Standard BioTools position peaked at $5.68M in Q1 2024.
- 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.